Sucrose Ester Cationic Lipid Gene Vector
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current gene therapy methods face limitations due to the low transfection efficiency and high toxicity of existing non-viral gene vectors, particularly cationic lipids, which hinder their clinical application, while viral vectors have drawbacks such as high immunogenicity and carcinogenicity.
Innovation Solution
Development of sucrose ester-based cationic lipid compounds and complexes, synthesized through specific esterification reactions, which form biocompatible and degradable gene vectors with improved transfection efficiency and reduced cytotoxicity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If viral vectors are used for gene delivery, then transfection efficiency is improved, but immunogenicity and carcinogenicity increase
Solution Approach 1:
The patent replaces persistent viral vectors with biodegradable sucrose ester-based cationic lipids that are metabolized by the body, eliminating long-term safety concerns while maintaining transfection efficiency. The sucrose ester structure is designed to be broken down into natural metabolites.
Solution Approach 2:
The invention creates composite cationic lipid structures combining sucrose ester backbone with hydrophobic tail groups, forming amphiphilic molecules that can self-assemble into liposomes for gene delivery. This composite structure provides both efficiency and safety.
2Object-affected harmful factors
If non-viral gene vectors are used, then immunogenicity and toxicity are reduced, but transfection efficiency decreases
Solution Approach 1:
The patent optimizes the cationic charge density and hydrophobicity parameters of the sucrose ester lipids to achieve optimal transfection efficiency. The cationic nitrogen groups provide electrostatic interaction with DNA while the hydrophobic tails enable membrane fusion, balancing efficiency and safety.
Solution Approach 2:
The sucrose ester cationic lipids act as intermediaries that facilitate DNA delivery without direct viral involvement. They form lipoplexes with DNA and mediate cellular uptake through endocytosis, providing a safe intermediate mechanism between non-viral vectors and cellular delivery.
3Productivity
If existing cationic lipids are used for gene delivery, then gene transport capability is achieved, but cytotoxicity increases
Solution Approach 1:
The sucrose ester-based cationic lipids are designed as biodegradable, short-lived delivery vehicles that are metabolized into natural sucrose and fatty acid components, eliminating persistent cytotoxicity while maintaining gene transport capability during the delivery window.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The sucrose ester-based cationic lipid vectors demonstrate superior transfection efficiency and lower cytotoxicity compared to existing reagents like Lipofectamine 2000 and DOTAP, offering a promising solution for safe and effective gene delivery.
Implementation Method 1
Sucrose ester prepared by using sucrose as a starting material can form a vesicular or double lamellar structure in the aqueous phase
Implementation Method 2
Cationic liposomes which are positively charged at a physiological pH, can be self-assembled with negatively charged phosphate groups in a nucleic acid molecule to form liposome/gene complexes by means of an electrostatic interaction
Implementation Method 3
the complexes can be adsorbed on the cell surface by the electrostatic interaction, and thereby introduce the exogenous genes into cells through cell endocytosis
Data Source
AI summary
The invention provides a class of sucrose ester based cationic lipids and preparation method thereof. The vector prepared using the cationic lipid can be used to deliver nucleic acid. The sucrose ester based cationic lipid is prepared by using a chemical synthesis method in the invention, wherein the synthesis method is simple, and has a relatively high product yield. A composition, including suspension, emulsion, micelle and liposome and the like, can be prepared by mixing the sucrose ester based cationic lipid compound of the invention with a co-lipid. Sucrose ester based cationic lipid complex can be prepared by using the said composition and nucleic acid, which has advantages such as simple preparation, low toxicity and high transfection efficiency, and is a novel and highly efficient gene vector.